A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment

Clinical trial NCT03092128 · UNKNOWN

Trial details

NCT number: NCT03092128
Sponsor: Xueding Wang
Status: UNKNOWN
Study type: OBSERVATIONAL

Gastrointestinal Stromal Tumors Germline Mutation Somatic Mutation Plasma Concentration

Start date: 2014-06-01
Primary completion: 2019-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.